252 related articles for article (PubMed ID: 35387749)
1. Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes.
de Vries M; El-Morabit F; van Erpecum KJ; Westerink J; Bac ST; Kaasjager HAHK; de Valk HW
Eur J Intern Med; 2022 Jun; 100():77-82. PubMed ID: 35387749
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.
Cusi K; Sanyal AJ; Zhang S; Hartman ML; Bue-Valleskey JM; Hoogwerf BJ; Haupt A
Diabetes Obes Metab; 2017 Nov; 19(11):1630-1634. PubMed ID: 28417532
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes.
de Vries M; Westerink J; El-Morabit F; Kaasjager HAHK; de Valk HW
Diabetes Res Clin Pract; 2022 Apr; 186():109827. PubMed ID: 35283265
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.
Li TT; Wang AP; Lu JX; Chen MY; Zhao CC; Tang ZH; Li LX; Jia WP
Diabetes Metab; 2018 Nov; 44(5):437-443. PubMed ID: 29631765
[TBL] [Abstract][Full Text] [Related]
5. Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes.
Saatmann N; Schön M; Zaharia OP; Huttasch M; Strassburger K; Trenkamp S; Kupriyanova Y; Schrauwen-Hinderling V; Kahl S; Burkart V; Wagner R; Roden M;
Liver Int; 2024 Jan; 44(1):27-38. PubMed ID: 37697960
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
Sae-Wong J; Chaopathomkul B; Phewplung T; Chaijitraruch N; Sahakitrungruang T
J Pediatr; 2021 Mar; 230():32-37.e1. PubMed ID: 33250172
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
8. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
Julián MT; Pera G; Soldevila B; Caballería L; Julve J; Puig-Jové C; Morillas R; Torán P; Expósito C; Puig-Domingo M; Castelblanco E; Franch-Nadal J; Cusi K; Mauricio D; Alonso N
Eur J Endocrinol; 2021 Apr; 184(4):587-596. PubMed ID: 33606661
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.
Memaj P; Jornayvaz FR
Front Endocrinol (Lausanne); 2022; 13():1031633. PubMed ID: 36531463
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Gerami H; Qorbani M; Bellissimo N; Poustchi H; Hekmatdoost A
Acta Diabetol; 2019 Nov; 56(11):1199-1207. PubMed ID: 31197470
[TBL] [Abstract][Full Text] [Related]
12. Metabolic determinants of NAFLD in adults with type 1 diabetes.
Serdarova M; Dimova R; Chakarova N; Grozeva G; Todorova A; Tsarkova P; Marinova C; Popov D; Mateva L; Tankova T
Diabetes Res Clin Pract; 2022 Apr; 186():109819. PubMed ID: 35248654
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis.
Ciardullo S; Perseghin G
Diabetes Res Clin Pract; 2022 Aug; 190():109981. PubMed ID: 35798217
[TBL] [Abstract][Full Text] [Related]
14. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
[TBL] [Abstract][Full Text] [Related]
15. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study.
Martínez-Ortega AJ; Piñar Gutiérrez A; Lara-Romero C; Remón Ruiz PJ; Ampuero-Herrojo J; de Lara-Rodríguez I; Romero-Gómez M; García Luna PP; Soto-Moreno A
Nutr Hosp; 2022 Oct; 39(5):1012-1018. PubMed ID: 36134588
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
Prasetya IB; Hasan I; Wisnu W; Rumende CM
Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
[TBL] [Abstract][Full Text] [Related]
18. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
Ciardullo S; Perseghin G
Metabolism; 2021 Aug; 121():154752. PubMed ID: 33716004
[TBL] [Abstract][Full Text] [Related]
19. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
[TBL] [Abstract][Full Text] [Related]
20. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
